NCT03781739View on ClinicalTrials.gov

MANP in Hypertension and Metabolic Syndrome

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 18, 2017

Primary Completion Date

November 14, 2019

Study Completion Date

December 10, 2019

Conditions
HypertensionMetabolic Syndrome
Interventions
DRUG

MANP

single subcutaneous injection of MANP and monitoring of metabolic, cardiovascular and renal parameters

Trial Locations (1)

55905

Mayo Foundation, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

Mayo Clinic

OTHER